| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/13/1998 | US5708015 Method for using pharmaceutical compositions containing 2-(2-alkyphenyl-amino)-thiazolines as adrenergic agents |
| 01/13/1998 | US5707991 N-acylpyrrolidines and medicaments for the treatment or prevention of disorders linked to CKK and to gastrin |
| 01/13/1998 | US5707829 DNA sequences and secreted proteins encoded thereby |
| 01/13/1998 | US5707635 Containing a crosslinked polyacrylamide-type polymer and an active compound, optionally a humectant and an emollient |
| 01/12/1998 | CA2210056A1 Cyclic sulfone derivatives |
| 01/08/1998 | WO1998000543A1 Hepatocyte growth factor receptor agonists and uses thereof |
| 01/08/1998 | WO1998000404A1 Anthranilic acid diamides derivatives, their preparation and pharmaceutical use as anti-gastrin agents |
| 01/08/1998 | WO1998000390A1 Smooth muscle spasmolytic agents, compositions and methods of use thereof |
| 01/08/1998 | WO1998000135A1 Treatment of sepsis-induced acute renal failure and renal vasoconstriction and catecholamine-induced renal and mesenteric vasoconstriction |
| 01/08/1998 | WO1998000127A1 Retinoyloxy(substituted)alkylene butyrates useful for the treatment of cancer and other proliferative diseases |
| 01/08/1998 | WO1998000115A2 Stable drug form for oral administration and process for the preparation thereof |
| 01/08/1998 | WO1998000114A2 Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
| 01/08/1998 | WO1997046255A3 Vaccine composition comprising outer membrane protein fragments of bordetella pertussis |
| 01/08/1998 | WO1997041824A3 Antiangiogenic peptides derived from plasminogen |
| 01/08/1998 | DE19627376A1 Verwendung von Artischocken-(Cynara)-Extrakten Use of artichoke (Cynara) extracts |
| 01/08/1998 | DE19626045A1 Stabile Arzneiform zur oralen Verabreichung sowie Verfahren zur Herstellung derselben Stable drug form for oral administration and methods for preparing the same |
| 01/08/1998 | CA2259316A1 Smooth muscle spasmolytic agents, compositions and methods of use thereof |
| 01/08/1998 | CA2258593A1 Retinoyloxy(substituted)alkylene butyrates useful for the treatment of cancer and other proliferative diseases |
| 01/07/1998 | EP0816497A2 Human requiem polypeptide for apoptosis |
| 01/07/1998 | EP0816375A1 Glycoconjugates of opiated substances |
| 01/07/1998 | EP0816357A1 Substituted indazole derivatives |
| 01/07/1998 | EP0815868A1 A chinese drug composition for treatment of peptic ulcer and preparation thereof |
| 01/07/1998 | EP0815865A2 Use of creosote and/or its constituents as an intestinal juice level regulator |
| 01/07/1998 | EP0815864A1 Semi-solid composition containing an antiflatulent agent |
| 01/07/1998 | EP0815855A1 Multiphase soft gelatin dosage form |
| 01/07/1998 | EP0815237A1 Threonyl-trna synthetase of staphylococcus aureus |
| 01/07/1998 | EP0815130A1 Casein phosphopeptide, casein containing same and process for the preparation thereof |
| 01/07/1998 | EP0815129A1 Ingap protein involved in pancreatic islet neogenesis |
| 01/07/1998 | EP0815126A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 01/07/1998 | EP0815107A1 Morpholine derivatives, compositions containing them and their use as therapeutic agents |
| 01/07/1998 | EP0815088A1 Aromatic compounds useful as tachykinin antagonists |
| 01/07/1998 | EP0815084A1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease |
| 01/07/1998 | EP0815080A1 Di-substituted 1,4-piperidine esters and amides having 5-ht 4? antagonistic activity |
| 01/07/1998 | EP0814840A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent |
| 01/07/1998 | EP0814815A1 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 01/07/1998 | EP0814812A1 Compositions comprising nicotynylalanine and an inhibitor of glycine conjugation or vitamin b6 |
| 01/07/1998 | EP0814796A2 Use of a r-nsaid in a protective composition for the treatment of colorectal cancer |
| 01/07/1998 | EP0814792A1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 01/07/1998 | EP0814784A1 Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx |
| 01/07/1998 | EP0814756A1 Method for preparing a preparation for bleaching teeth or for treating skin complaints and mucous membrane disorders |
| 01/07/1998 | EP0700301A4 Peptides and compounds that bind to elam-1 |
| 01/07/1998 | EP0613458B1 Acyclic ethylenediamine derivatives as substance p receptor antagonists |
| 01/07/1998 | CN1169429A Sulfamine-substituted benzodihydopyran, preparation method, use as medicine or diagnostic reagent and medicine containing same |
| 01/07/1998 | CN1169304A Pill made from eight Chinese medicinal herbs and production technology thereof |
| 01/07/1998 | CN1036920C Heterocycle-containing carbonic acid derivatives |
| 01/06/1998 | US5705615 Antibodies specific for HTm4 |
| 01/06/1998 | US5705525 Thiophene compounds |
| 01/06/1998 | US5705515 Having reduced side effects |
| 01/06/1998 | US5705509 Tricyclic heterocyclic compounds as 5-HT4 receptor antagonists |
| 01/06/1998 | US5705504 Platelet activating factor |
| 01/06/1998 | US5705494 Anti-estrogenic activity of IIβ-substituted-19-NOR Steroids |
| 01/06/1998 | US5705360 Chemokine N-terminal deletion mutations |
| 12/31/1997 | WO1997049710A1 Spiro-piperidine derivatives and their use as therapeutic agents |
| 12/31/1997 | WO1997049708A1 Tricyclic benzazepine vasopressin antagonists |
| 12/31/1997 | WO1997049707A1 Tricyclic benzazepine vasopressin antagonists |
| 12/31/1997 | WO1997049702A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| 12/31/1997 | WO1997049680A1 Il-8 receptor antagonists |
| 12/31/1997 | WO1997049420A1 Lectin compositions and uses thereof |
| 12/31/1997 | WO1997049406A1 Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 12/31/1997 | WO1997049286A1 Il-8 receptor antagonists |
| 12/31/1997 | WO1997038726A3 Hydrophobic carbomer complex compositions |
| 12/31/1997 | CN1169142A Compound for inhibition of gastric acid secretion |
| 12/31/1997 | CN1168891A Method for preparing chelate of antibiotic and complex metallic salt |
| 12/31/1997 | CN1168797A Medicine for treating cholelithiosis (stone-removing powder medicine) |
| 12/31/1997 | CN1168794A Method of reducing tissue damage associated with non-cardiac ischemia |
| 12/31/1997 | CA2258885A1 Tricyclic benzazepine vasopressin antagonists |
| 12/31/1997 | CA2258850A1 Il-8 receptor antagonists |
| 12/31/1997 | CA2257964A1 Spiro-piperidine derivatives and their use as therapeutic agents |
| 12/30/1997 | US5703240 Analgesics; antiinflammatory agents; nervous system disorders; psychological disorders; gastrointestinal disorders |
| 12/30/1997 | US5703118 Use of benzopyran derivatives for the treatment of pathologies associated with the NA+ -independent CI-/HCO3 -exchanger |
| 12/30/1997 | US5703112 Method of preventing emesis using tetrahydrobenz CD!indole-6-carbonxamides |
| 12/30/1997 | US5703106 Treating various cardiovascular, urogenital, brain disorders |
| 12/30/1997 | US5703100 Modulators of acetylcholine receptors |
| 12/30/1997 | US5703099 Treatment of thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer or hypertension |
| 12/30/1997 | US5703097 Antiulcer agents |
| 12/30/1997 | US5703077 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 12/30/1997 | US5703073 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 12/30/1997 | US5703048 Hepatocyte growth factor |
| 12/30/1997 | CA2024479C Quinone derivatives and pharmacological use |
| 12/29/1997 | EP0814158A2 Human C3a receptor variant; uses in diagnostics and therapeutics |
| 12/29/1997 | EP0813871A1 Berberine derivates for inhibiting production of HSP47 |
| 12/29/1997 | EP0813529A1 Arginine analogues having nitric oxide synthase inhibitor activity |
| 12/29/1997 | EP0813520A1 Arylsulfonylamino hydroxamic acid derivatives |
| 12/29/1997 | EP0813424A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
| 12/29/1997 | EP0813407A1 Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate |
| 12/24/1997 | WO1997048713A1 Macrocyclic 13-membered ring derivatives of erythromycins a and b |
| 12/24/1997 | WO1997048693A1 Isocoumarin derivatives and use thereof in drugs |
| 12/24/1997 | WO1997048682A1 Heterocyclylmethylamino derivatives of cyclobutene-3,4-diones as potassium channel modulators |
| 12/24/1997 | WO1997048380A1 ADMINISTRATION REGIMEN OF H+, K+-ATPase INHIBITORS |
| 12/24/1997 | WO1997042941A3 Buccal delivery system |
| 12/24/1997 | WO1997036497A3 Cocoa extract compounds and methods for making and using the same |
| 12/24/1997 | CN1168693A Method for producing enhanced antigenic enteric bacteria and vaccines comprising same |
| 12/24/1997 | CN1168678A Method of treating diabetes mellitus using KGF |
| 12/24/1997 | CN1168672A 2,7-substituierte octahydro-1H-pyrido £1,2-A| pyrazin derivate |
| 12/24/1997 | CA2258536A1 Heterocyclylmethylamino derivatives of cyclobutene-3,4-diones as potassium channel modulators |
| 12/24/1997 | CA2257405A1 Administration regimen of h+, k+-atpase inhibitors |
| 12/24/1997 | CA2257361A1 Macrocyclic 13-membered ring derivatives of erythromycins a and b |
| 12/23/1997 | US5700838 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 12/23/1997 | US5700827 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions (II) containing these compounds |
| 12/23/1997 | US5700818 Serotonin antagonists for treatment of nervous system, brain or psychological disorders |